We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$2.01B
AUM Growth
+$202M
Cap. Flow
+$14.9M
Cap. Flow %
0.74%
Top 10 Hldgs %
34.18%
Holding
238
New
11
Increased
56
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
TDC icon
Teradata
TDC
+$19M
2
UNH icon
UnitedHealth
UNH
+$15.2M
3
INTU icon
Intuit
INTU
+$11M
4
TSM icon
TSMC
TSM
+$9.83M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$9.27M

Top Sells

Rank Stock Value
1
ALBO
Albireo Pharma Inc
ALBO
+$29.4M
2
SIVB
SVB Financial Group
SIVB
+$23.7M
3
EW icon
Edwards Lifesciences
EW
+$20.7M
4
CCSI icon
Consensus Cloud Solutions
CCSI
+$13.6M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.58%
2 Healthcare 21.34%
3 Financials 14.12%
4 Communication Services 11.1%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APO icon
176
Apollo Global Management
APO
$72.4B
$359K 0.02%
5,690
+94
+2% +$6.29K
GILD icon
177
Gilead Sciences
GILD
$162B
$356K 0.02%
4,294
– –
QCOM icon
178
Qualcomm
QCOM
$155B
$354K 0.02%
2,771
-179
-6% -$22.3K
OGE icon
179
OGE Energy
OGE
$9.78B
$350K 0.02%
9,300
– –
VCSH icon
180
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$342K 0.02%
4,487
-328
-7% -$24.8K
GOGO icon
181
Gogo Inc
GOGO
$565M
$340K 0.02%
23,460
+2,609
+13% +$40.7K
COP icon
182
ConocoPhillips
COP
$147B
$331K 0.02%
3,341
– –
EVH icon
183
Evolent Health
EVH
$348M
$327K 0.02%
10,073
– –
NSC icon
184
Norfolk Southern
NSC
$75.4B
$327K 0.02%
1,541
-32
-2% -$7.4K
GLW icon
185
Corning
GLW
$119B
$324K 0.02%
9,173
– –
WEX icon
186
WEX
WEX
$6.37B
$318K 0.02%
1,728
– –
TTWO icon
187
Take-Two Interactive
TTWO
$45.4B
$315K 0.02%
2,644
+347
+15% +$38.7K
POOL icon
188
Pool Corp
POOL
$6.75B
$315K 0.02%
920
– –
GLD icon
189
SPDR Gold Trust
GLD
$131B
$306K 0.02%
1,670
– –
EXAS
190
DELISTED
Exact Sciences
EXAS
$302K 0.02%
4,451
– –
MRNA icon
191
Moderna
MRNA
$21.8B
$300K 0.01%
1,955
– –
RYAN icon
192
Ryan Specialty Holdings
RYAN
$5.72B
$299K 0.01%
+7,435
New +$306K
TECH icon
193
Bio-Techne
TECH
$11.2B
$297K 0.01%
4,000
– –
ABNB icon
194
Airbnb
ABNB
$89.9B
$291K 0.01%
+2,338
New +$267K
CAH icon
195
Cardinal Health
CAH
$53.9B
$287K 0.01%
3,805
– –
SHEL icon
196
Shell
SHEL
$254B
$270K 0.01%
4,701
– –
ETR icon
197
Entergy
ETR
$50.2B
$268K 0.01%
4,978
– –
USB icon
198
US Bancorp
USB
$98.2B
$266K 0.01%
7,384
-3,956
-35% -$176K
BALL icon
199
Ball Corp
BALL
$17.3B
$265K 0.01%
4,800
– –
TEAM icon
200
Atlassian
TEAM
$25.6B
$264K 0.01%
1,544
-21
-1% -$3.35K
6 7
8
9 10

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Chicago Capital held 238 positions worth $2.01B, up 11% from $1.81B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Chicago Capital's Q1 2023 filing shows 11 new, 56 increased, 56 reduced and 10 closed positions. Its largest new stake was Factset: 1,141 shares worth $474K. The largest sale was Albireo Pharma Inc, an estimated $29.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Chicago Capital's largest Q1 2023 buy was Factset: 1,141 shares worth $474K.
  • Chicago Capital added most to Teradata in Q1 2023, an estimated $19M increase.
  • Chicago Capital's biggest Q1 2023 reduction was Edwards Lifesciences, cutting an estimated $20.7M.
  • Chicago Capital fully exited Albireo Pharma Inc in Q1 2023, selling an estimated $29.4M.
  • Chicago Capital's ten largest holdings make up 34% of its $2.01B portfolio in Q1 2023.
  • Chicago Capital opened 11 new positions and closed 10 in Q1 2023.
  • Chicago Capital's portfolio value rose 11% quarter-over-quarter to $2.01B.

Based on Chicago Capital's 13F filing for Q1 2023, filed 18 Apr 2023.